

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.02017198 |
| 2 | central nervous system myelination (GO:0022010) | 6.02017198 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.85133955 |
| 4 | dopamine biosynthetic process (GO:0042416) | 5.48041298 |
| 5 | proteasome assembly (GO:0043248) | 5.45448310 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.21009181 |
| 7 | dopamine transport (GO:0015872) | 5.17971357 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.16576303 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.97934101 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 4.97934101 |
| 11 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.71991200 |
| 12 | establishment of integrated proviral latency (GO:0075713) | 4.47972510 |
| 13 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.39847867 |
| 14 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.34441252 |
| 15 | CENP-A containing nucleosome assembly (GO:0034080) | 4.33243564 |
| 16 | chromatin remodeling at centromere (GO:0031055) | 4.30656564 |
| 17 | presynaptic membrane assembly (GO:0097105) | 4.30378825 |
| 18 | negative regulation of ligase activity (GO:0051352) | 4.29177930 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.29177930 |
| 20 | negative regulation of neurotransmitter transport (GO:0051589) | 4.28203937 |
| 21 | respiratory electron transport chain (GO:0022904) | 4.28203491 |
| 22 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.24703161 |
| 23 | regulation of dopamine metabolic process (GO:0042053) | 4.23473990 |
| 24 | regulation of catecholamine metabolic process (GO:0042069) | 4.23473990 |
| 25 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.19445364 |
| 26 | electron transport chain (GO:0022900) | 4.17844588 |
| 27 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.16663415 |
| 28 | ribosomal large subunit biogenesis (GO:0042273) | 4.11180466 |
| 29 | rRNA modification (GO:0000154) | 4.07194700 |
| 30 | regulation of mitochondrial translation (GO:0070129) | 4.05412200 |
| 31 | fatty acid elongation (GO:0030497) | 4.02360808 |
| 32 | presynaptic membrane organization (GO:0097090) | 4.01719267 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 4.00329030 |
| 34 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.98187050 |
| 35 | termination of RNA polymerase III transcription (GO:0006386) | 3.98056640 |
| 36 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.98056640 |
| 37 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.94188566 |
| 38 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.94188566 |
| 39 | NADH dehydrogenase complex assembly (GO:0010257) | 3.94188566 |
| 40 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.88755929 |
| 41 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.85258292 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.84049780 |
| 43 | cotranslational protein targeting to membrane (GO:0006613) | 3.83946552 |
| 44 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.79997639 |
| 45 | viral transcription (GO:0019083) | 3.78175362 |
| 46 | protein targeting to ER (GO:0045047) | 3.77734819 |
| 47 | translational termination (GO:0006415) | 3.77332258 |
| 48 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.76071105 |
| 49 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.76071105 |
| 50 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.76071105 |
| 51 | mating behavior (GO:0007617) | 3.75469907 |
| 52 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.74697700 |
| 53 | chaperone-mediated protein transport (GO:0072321) | 3.74326502 |
| 54 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.74076068 |
| 55 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.74076068 |
| 56 | neuron recognition (GO:0008038) | 3.72348530 |
| 57 | synaptic transmission, dopaminergic (GO:0001963) | 3.71233009 |
| 58 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.71020719 |
| 59 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.70789817 |
| 60 | respiratory chain complex IV assembly (GO:0008535) | 3.68965257 |
| 61 | neuron remodeling (GO:0016322) | 3.66425334 |
| 62 | protein targeting to mitochondrion (GO:0006626) | 3.65951611 |
| 63 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.63561290 |
| 64 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.63128904 |
| 65 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.63128904 |
| 66 | * translation (GO:0006412) | 3.63003640 |
| 67 | establishment of viral latency (GO:0019043) | 3.60367026 |
| 68 | protein neddylation (GO:0045116) | 3.59436452 |
| 69 | catecholamine transport (GO:0051937) | 3.59431320 |
| 70 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.58275896 |
| 71 | positive regulation of ligase activity (GO:0051351) | 3.58019975 |
| 72 | protein localization to endoplasmic reticulum (GO:0070972) | 3.56750761 |
| 73 | catecholamine biosynthetic process (GO:0042423) | 3.55536345 |
| 74 | catechol-containing compound biosynthetic process (GO:0009713) | 3.55536345 |
| 75 | maturation of SSU-rRNA (GO:0030490) | 3.54873664 |
| 76 | spliceosomal snRNP assembly (GO:0000387) | 3.53844933 |
| 77 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.52523277 |
| 78 | positive regulation of synapse assembly (GO:0051965) | 3.52480748 |
| 79 | oxidative phosphorylation (GO:0006119) | 3.52275881 |
| 80 | cullin deneddylation (GO:0010388) | 3.51864930 |
| 81 | substantia nigra development (GO:0021762) | 3.51575589 |
| 82 | myelination (GO:0042552) | 3.50512015 |
| 83 | protein localization to mitochondrion (GO:0070585) | 3.48243838 |
| 84 | histone exchange (GO:0043486) | 3.46878463 |
| 85 | ensheathment of neurons (GO:0007272) | 3.44471543 |
| 86 | axon ensheathment (GO:0008366) | 3.44471543 |
| 87 | ribosomal small subunit biogenesis (GO:0042274) | 3.44460805 |
| 88 | glycerophospholipid catabolic process (GO:0046475) | 3.43137664 |
| 89 | cytochrome complex assembly (GO:0017004) | 3.40966045 |
| 90 | establishment of protein localization to mitochondrion (GO:0072655) | 3.40026691 |
| 91 | neuronal action potential propagation (GO:0019227) | 3.39727547 |
| 92 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.39616033 |
| 93 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.38155413 |
| 94 | purine nucleobase biosynthetic process (GO:0009113) | 3.37246417 |
| 95 | DNA replication checkpoint (GO:0000076) | 3.36462151 |
| 96 | neurotransmitter catabolic process (GO:0042135) | 3.36370828 |
| 97 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.36339370 |
| 98 | ATP biosynthetic process (GO:0006754) | 3.36076800 |
| 99 | translational initiation (GO:0006413) | 3.34555753 |
| 100 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.33161706 |
| 101 | protein localization to synapse (GO:0035418) | 3.32946822 |
| 102 | glutamate receptor signaling pathway (GO:0007215) | 3.31343137 |
| 103 | rRNA methylation (GO:0031167) | 3.28460051 |
| 104 | mitotic metaphase plate congression (GO:0007080) | 3.28345214 |
| 105 | DNA damage response, detection of DNA damage (GO:0042769) | 3.27841577 |
| 106 | vocalization behavior (GO:0071625) | 3.27495219 |
| 107 | regulation of ligase activity (GO:0051340) | 3.27071503 |
| 108 | ribosome assembly (GO:0042255) | 3.25664051 |
| 109 | translational elongation (GO:0006414) | 3.25290765 |
| 110 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24228969 |
| 111 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24228969 |
| 112 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.23449005 |
| 113 | DNA replication-independent nucleosome organization (GO:0034724) | 3.23449005 |
| 114 | pseudouridine synthesis (GO:0001522) | 3.22667931 |
| 115 | protein deneddylation (GO:0000338) | 3.22097290 |
| 116 | regulation of glutamate secretion (GO:0014048) | 3.21449504 |
| 117 | cellular component biogenesis (GO:0044085) | 3.19574431 |
| 118 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.18637310 |
| 119 | DNA strand elongation (GO:0022616) | 3.17234637 |
| 120 | histone mRNA metabolic process (GO:0008334) | 3.14030478 |
| 121 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.13929677 |
| 122 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.13929677 |
| 123 | DNA double-strand break processing (GO:0000729) | 3.13001490 |
| 124 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.11929369 |
| 125 | regulation of vesicle fusion (GO:0031338) | 3.11634156 |
| 126 | rRNA processing (GO:0006364) | 3.10773553 |
| 127 | nucleobase biosynthetic process (GO:0046112) | 3.07924732 |
| 128 | regulation of protein kinase A signaling (GO:0010738) | 3.07592153 |
| 129 | response to cocaine (GO:0042220) | 3.03498055 |
| 130 | behavioral response to cocaine (GO:0048148) | 3.02312899 |
| 131 | negative regulation of protein ubiquitination (GO:0031397) | 3.01844439 |
| 132 | metaphase plate congression (GO:0051310) | 3.01521980 |
| 133 | intracellular protein transmembrane import (GO:0044743) | 3.01202249 |
| 134 | telomere maintenance via recombination (GO:0000722) | 3.00986955 |
| 135 | phenol-containing compound catabolic process (GO:0019336) | 3.00833530 |
| 136 | negative regulation of protein localization to cell surface (GO:2000009) | 3.00128361 |
| 137 | cellular response to epinephrine stimulus (GO:0071872) | 2.98938654 |
| 138 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.97942901 |
| 139 | neuron-neuron synaptic transmission (GO:0007270) | 2.97304855 |
| 140 | oligodendrocyte differentiation (GO:0048709) | 2.93677403 |
| 141 | regulation of collateral sprouting (GO:0048670) | 2.92976014 |
| 142 | postsynaptic membrane organization (GO:0001941) | 2.90838458 |
| 143 | axonal fasciculation (GO:0007413) | 2.90198970 |
| 144 | synaptic vesicle exocytosis (GO:0016079) | 2.88834828 |
| 145 | cholesterol biosynthetic process (GO:0006695) | 2.87561161 |
| 146 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.86087566 |
| 147 | hydrogen ion transmembrane transport (GO:1902600) | 2.84834154 |
| 148 | limb bud formation (GO:0060174) | 2.79401919 |
| 149 | adult walking behavior (GO:0007628) | 2.77470651 |
| 150 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.74741299 |
| 151 | GTP biosynthetic process (GO:0006183) | 2.74672388 |
| 152 | response to epinephrine (GO:0071871) | 2.72829995 |
| 153 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.72577169 |
| 154 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.72577169 |
| 155 | synaptic transmission, glutamatergic (GO:0035249) | 2.72157407 |
| 156 | response to redox state (GO:0051775) | 2.71204092 |
| 157 | exploration behavior (GO:0035640) | 2.70355755 |
| 158 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.70094341 |
| 159 | alkaloid metabolic process (GO:0009820) | 2.69529902 |
| 160 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.68368493 |
| 161 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.68087187 |
| 162 | neurotransmitter uptake (GO:0001504) | 2.66638392 |
| 163 | negative regulation of axon extension (GO:0030517) | 2.65917292 |
| 164 | locomotory exploration behavior (GO:0035641) | 2.65494874 |
| 165 | response to histamine (GO:0034776) | 2.63728520 |
| 166 | proton transport (GO:0015992) | 2.63445453 |
| 167 | inner mitochondrial membrane organization (GO:0007007) | 2.63366720 |
| 168 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.62739642 |
| 169 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.62435293 |
| 170 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.62025835 |
| 171 | positive regulation of response to oxidative stress (GO:1902884) | 2.62025835 |
| 172 | dendritic spine morphogenesis (GO:0060997) | 2.61397889 |
| 173 | dopamine metabolic process (GO:0042417) | 2.58580474 |
| 174 | neurotransmitter biosynthetic process (GO:0042136) | 2.58549671 |
| 175 | hydrogen transport (GO:0006818) | 2.57901016 |
| 176 | neural nucleus development (GO:0048857) | 2.55098956 |
| 177 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.54328894 |
| 178 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.51509414 |
| 179 | protein localization to cilium (GO:0061512) | 2.51411507 |
| 180 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.51200566 |
| 181 | regulation of synapse assembly (GO:0051963) | 2.51012430 |
| 182 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.50779350 |
| 183 | sterol biosynthetic process (GO:0016126) | 2.50524026 |
| 184 | synapse assembly (GO:0007416) | 2.50435102 |
| 185 | histone H2B ubiquitination (GO:0033523) | 2.49508057 |
| 186 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.46763801 |
| 187 | protein complex biogenesis (GO:0070271) | 2.46734737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.68247292 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.85657961 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.79507092 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.47483380 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.36480278 |
| 6 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.75988870 |
| 7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.65518437 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56864764 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.45175923 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.43323644 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.31105263 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.23950500 |
| 13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.19624719 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.17285253 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.14350001 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.03693315 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.01330019 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89994119 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87357838 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.76051624 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.72412025 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.65812292 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.63643538 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.62018088 |
| 25 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.56001189 |
| 26 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.52926645 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51949352 |
| 28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.51795321 |
| 29 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.50013255 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.47728524 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43599986 |
| 32 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43599986 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 2.42419693 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42231099 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41756949 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38165524 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.38081006 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.37163733 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.33750184 |
| 40 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.20473284 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19846320 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.19552251 |
| 43 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.19267786 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18626199 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.15113142 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13684832 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12208045 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.11866973 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07287716 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.07016113 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.06057179 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.05906485 |
| 53 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04457533 |
| 54 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03901613 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.00889314 |
| 56 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.00750876 |
| 57 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.00179472 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.97981282 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.97597874 |
| 60 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94846958 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.91916765 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.91141454 |
| 63 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.90815701 |
| 64 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.88398440 |
| 65 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.87474053 |
| 66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84639432 |
| 67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.84638351 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.79245071 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77603604 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76769116 |
| 71 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76709454 |
| 72 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.76455355 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.76102288 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73977366 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73562374 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.63140089 |
| 77 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.62291461 |
| 78 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.61564204 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61329626 |
| 80 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60252611 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.60118321 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59689036 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59263705 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58157817 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57357776 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.56976264 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53999367 |
| 88 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.52819238 |
| 89 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.50090900 |
| 90 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.49134174 |
| 91 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46726543 |
| 92 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46252304 |
| 93 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.45907881 |
| 94 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44540352 |
| 95 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43904248 |
| 96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43210980 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41975639 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40776566 |
| 99 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.40626036 |
| 100 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.38369886 |
| 101 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.37375932 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36014165 |
| 103 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35018621 |
| 104 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34525112 |
| 105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33383768 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29129636 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.29096861 |
| 108 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.29017679 |
| 109 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.27335716 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24927038 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24378523 |
| 112 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.23046466 |
| 113 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21937401 |
| 114 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21790281 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18178894 |
| 116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17944338 |
| 117 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15568544 |
| 118 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15067769 |
| 119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14473890 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14196671 |
| 121 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13582353 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11015378 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10469951 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10030090 |
| 125 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09846635 |
| 126 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09723110 |
| 127 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.09278559 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08831174 |
| 129 | JUN_21703547_ChIP-Seq_K562_Human | 1.08615439 |
| 130 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07214189 |
| 131 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06693728 |
| 132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06563609 |
| 133 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.06188722 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04983674 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04166416 |
| 136 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02182131 |
| 137 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01904097 |
| 138 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01567786 |
| 139 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00185148 |
| 140 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99991466 |
| 141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99713915 |
| 142 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99428387 |
| 143 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99103580 |
| 144 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98904869 |
| 145 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.98789461 |
| 146 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97991209 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97705797 |
| 148 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97576291 |
| 149 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97044467 |
| 150 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96745980 |
| 151 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.96377394 |
| 152 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94817605 |
| 153 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94566119 |
| 154 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94447728 |
| 155 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94398384 |
| 156 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93983111 |
| 157 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93488143 |
| 158 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92942923 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92796889 |
| 160 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92374755 |
| 161 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92123403 |
| 162 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91661724 |
| 163 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91053632 |
| 164 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90678089 |
| 165 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90341910 |
| 166 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90341910 |
| 167 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.87440983 |
| 168 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85922436 |
| 169 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85400293 |
| 170 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84036672 |
| 171 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.81497889 |
| 172 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78427023 |
| 173 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.76718848 |
| 174 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.75526568 |
| 175 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.75115747 |
| 176 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75099826 |
| 177 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.74509023 |
| 178 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74105482 |
| 179 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73850908 |
| 180 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.70104024 |
| 181 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69487093 |
| 182 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.68395021 |
| 183 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.67698896 |
| 184 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.65476298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.83788582 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.04890169 |
| 3 | MP0008058_abnormal_DNA_repair | 3.98983959 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.84908506 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.84816748 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.75735852 |
| 7 | MP0001529_abnormal_vocalization | 3.43986132 |
| 8 | MP0001905_abnormal_dopamine_level | 3.32456862 |
| 9 | MP0006276_abnormal_autonomic_nervous | 3.14423702 |
| 10 | MP0003941_abnormal_skin_development | 2.98603089 |
| 11 | MP0004270_analgesia | 2.93601891 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.90075478 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.87932990 |
| 14 | MP0003077_abnormal_cell_cycle | 2.87929234 |
| 15 | MP0003718_maternal_effect | 2.85570013 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.78123916 |
| 17 | MP0009697_abnormal_copulation | 2.77956815 |
| 18 | MP0009745_abnormal_behavioral_response | 2.77770329 |
| 19 | MP0002064_seizures | 2.74688242 |
| 20 | MP0005409_darkened_coat_color | 2.65685183 |
| 21 | MP0008932_abnormal_embryonic_tissue | 2.61852256 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.61704237 |
| 23 | MP0003186_abnormal_redox_activity | 2.60610779 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.51283952 |
| 25 | MP0009379_abnormal_foot_pigmentation | 2.49638745 |
| 26 | MP0002272_abnormal_nervous_system | 2.47482743 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 2.43353953 |
| 28 | MP0001486_abnormal_startle_reflex | 2.41954303 |
| 29 | MP0009046_muscle_twitch | 2.40943970 |
| 30 | MP0008007_abnormal_cellular_replicative | 2.35140212 |
| 31 | MP0001440_abnormal_grooming_behavior | 2.34801819 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 2.31839596 |
| 33 | MP0003786_premature_aging | 2.29375116 |
| 34 | MP0000778_abnormal_nervous_system | 2.25540358 |
| 35 | MP0002736_abnormal_nociception_after | 2.21810790 |
| 36 | MP0003136_yellow_coat_color | 2.21547522 |
| 37 | MP0002063_abnormal_learning/memory/cond | 2.14580982 |
| 38 | MP0000920_abnormal_myelination | 2.13791066 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 2.11792442 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 2.07435275 |
| 41 | MP0004142_abnormal_muscle_tone | 2.03843242 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.96264884 |
| 43 | MP0004742_abnormal_vestibular_system | 1.94897322 |
| 44 | MP0008057_abnormal_DNA_replication | 1.94578331 |
| 45 | MP0005171_absent_coat_pigmentation | 1.86647269 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.84174919 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.84089605 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.82921795 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.78097092 |
| 50 | MP0003329_amyloid_beta_deposits | 1.77221648 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.76321279 |
| 52 | MP0001970_abnormal_pain_threshold | 1.75526370 |
| 53 | MP0001293_anophthalmia | 1.73794107 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 1.73278555 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.69251890 |
| 56 | MP0002163_abnormal_gland_morphology | 1.66371258 |
| 57 | MP0005386_behavior/neurological_phenoty | 1.66240274 |
| 58 | MP0004924_abnormal_behavior | 1.66240274 |
| 59 | MP0001188_hyperpigmentation | 1.60656550 |
| 60 | MP0002184_abnormal_innervation | 1.60338371 |
| 61 | MP0005408_hypopigmentation | 1.57360657 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.49364593 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.43015486 |
| 64 | MP0006072_abnormal_retinal_apoptosis | 1.40469456 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.40211038 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.35178082 |
| 67 | MP0008995_early_reproductive_senescence | 1.34301668 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 1.33721094 |
| 69 | MP0002822_catalepsy | 1.33469564 |
| 70 | MP0004147_increased_porphyrin_level | 1.32193151 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.31158949 |
| 72 | MP0000955_abnormal_spinal_cord | 1.30229836 |
| 73 | MP0001764_abnormal_homeostasis | 1.30210778 |
| 74 | MP0004885_abnormal_endolymph | 1.27497058 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.25510566 |
| 76 | MP0003690_abnormal_glial_cell | 1.24730880 |
| 77 | MP0003315_abnormal_perineum_morphology | 1.22659558 |
| 78 | MP0006292_abnormal_olfactory_placode | 1.21939378 |
| 79 | MP0010030_abnormal_orbit_morphology | 1.20234138 |
| 80 | MP0000462_abnormal_digestive_system | 1.19983505 |
| 81 | MP0003634_abnormal_glial_cell | 1.19141266 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19046339 |
| 83 | MP0002752_abnormal_somatic_nervous | 1.18335143 |
| 84 | MP0002210_abnormal_sex_determination | 1.17234679 |
| 85 | MP0003122_maternal_imprinting | 1.17164805 |
| 86 | MP0003938_abnormal_ear_development | 1.16265480 |
| 87 | MP0003011_delayed_dark_adaptation | 1.14655929 |
| 88 | MP0004145_abnormal_muscle_electrophysio | 1.14650515 |
| 89 | MP0002229_neurodegeneration | 1.14108723 |
| 90 | MP0000358_abnormal_cell_content/ | 1.14006491 |
| 91 | MP0000350_abnormal_cell_proliferation | 1.12973356 |
| 92 | MP0002160_abnormal_reproductive_system | 1.10188851 |
| 93 | MP0001697_abnormal_embryo_size | 1.09799368 |
| 94 | MP0001984_abnormal_olfaction | 1.08304561 |
| 95 | MP0000631_abnormal_neuroendocrine_gland | 1.08266499 |
| 96 | MP0001963_abnormal_hearing_physiology | 1.07155482 |
| 97 | MP0001929_abnormal_gametogenesis | 1.07102730 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 1.06954621 |
| 99 | MP0005410_abnormal_fertilization | 1.06655375 |
| 100 | MP0003890_abnormal_embryonic-extraembry | 1.06196511 |
| 101 | MP0003632_abnormal_nervous_system | 1.04483974 |
| 102 | MP0004215_abnormal_myocardial_fiber | 1.03370513 |
| 103 | MP0001727_abnormal_embryo_implantation | 1.03366088 |
| 104 | MP0000647_abnormal_sebaceous_gland | 1.02511323 |
| 105 | MP0001730_embryonic_growth_arrest | 1.00965360 |
| 106 | MP0001286_abnormal_eye_development | 0.99550897 |
| 107 | MP0004381_abnormal_hair_follicle | 0.98530465 |
| 108 | MP0001145_abnormal_male_reproductive | 0.98449655 |
| 109 | MP0000653_abnormal_sex_gland | 0.97945720 |
| 110 | MP0002102_abnormal_ear_morphology | 0.97073888 |
| 111 | MP0000026_abnormal_inner_ear | 0.96978825 |
| 112 | MP0003937_abnormal_limbs/digits/tail_de | 0.96707271 |
| 113 | MP0005332_abnormal_amino_acid | 0.96369652 |
| 114 | MP0001664_abnormal_digestion | 0.96134566 |
| 115 | MP0002152_abnormal_brain_morphology | 0.93728252 |
| 116 | MP0003121_genomic_imprinting | 0.92081791 |
| 117 | MP0005253_abnormal_eye_physiology | 0.91566725 |
| 118 | MP0008872_abnormal_physiological_respon | 0.91376209 |
| 119 | MP0003123_paternal_imprinting | 0.89476657 |
| 120 | MP0005646_abnormal_pituitary_gland | 0.88165894 |
| 121 | MP0003195_calcinosis | 0.86576715 |
| 122 | MP0005645_abnormal_hypothalamus_physiol | 0.85559595 |
| 123 | MP0002085_abnormal_embryonic_tissue | 0.85384845 |
| 124 | MP0002233_abnormal_nose_morphology | 0.85274554 |
| 125 | MP0005395_other_phenotype | 0.84352403 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.81452445 |
| 127 | MP0005389_reproductive_system_phenotype | 0.81417540 |
| 128 | MP0008569_lethality_at_weaning | 0.81248515 |
| 129 | MP0000313_abnormal_cell_death | 0.81109975 |
| 130 | MP0002751_abnormal_autonomic_nervous | 0.80947867 |
| 131 | MP0001881_abnormal_mammary_gland | 0.80502694 |
| 132 | MP0003631_nervous_system_phenotype | 0.80396789 |
| 133 | MP0002638_abnormal_pupillary_reflex | 0.79383990 |
| 134 | MP0002080_prenatal_lethality | 0.78008444 |
| 135 | MP0005195_abnormal_posterior_eye | 0.77210059 |
| 136 | MP0002697_abnormal_eye_size | 0.76978076 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.76417384 |
| 138 | MP0005380_embryogenesis_phenotype | 0.76410282 |
| 139 | MP0001672_abnormal_embryogenesis/_devel | 0.76410282 |
| 140 | MP0005499_abnormal_olfactory_system | 0.75687151 |
| 141 | MP0005394_taste/olfaction_phenotype | 0.75687151 |
| 142 | MP0004811_abnormal_neuron_physiology | 0.74457123 |
| 143 | MP0002084_abnormal_developmental_patter | 0.74284051 |
| 144 | MP0001502_abnormal_circadian_rhythm | 0.74077436 |
| 145 | MP0005535_abnormal_body_temperature | 0.73263283 |
| 146 | MP0000604_amyloidosis | 0.72597534 |
| 147 | MP0005085_abnormal_gallbladder_physiolo | 0.72239401 |
| 148 | MP0008789_abnormal_olfactory_epithelium | 0.71784855 |
| 149 | MP0002876_abnormal_thyroid_physiology | 0.71687645 |
| 150 | MP0005636_abnormal_mineral_homeostasis | 0.71351979 |
| 151 | MP0002111_abnormal_tail_morphology | 0.71149319 |
| 152 | MP0003119_abnormal_digestive_system | 0.70987158 |
| 153 | MP0001119_abnormal_female_reproductive | 0.69811672 |
| 154 | MP0001853_heart_inflammation | 0.68402680 |
| 155 | MP0002095_abnormal_skin_pigmentation | 0.66973476 |
| 156 | MP0004085_abnormal_heartbeat | 0.66788954 |
| 157 | MP0001986_abnormal_taste_sensitivity | 0.66788562 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.66617483 |
| 159 | MP0002234_abnormal_pharynx_morphology | 0.66415046 |
| 160 | MP0005391_vision/eye_phenotype | 0.66288726 |
| 161 | MP0003950_abnormal_plasma_membrane | 0.66080986 |
| 162 | MP0001943_abnormal_respiration | 0.65226572 |
| 163 | MP0000751_myopathy | 0.65108445 |
| 164 | MP0005075_abnormal_melanosome_morpholog | 0.64351059 |
| 165 | MP0002295_abnormal_pulmonary_circulatio | 0.64238722 |
| 166 | MP0002938_white_spotting | 0.63875316 |
| 167 | MP0001346_abnormal_lacrimal_gland | 0.62265467 |
| 168 | MP0008874_decreased_physiological_sensi | 0.60272373 |
| 169 | MP0002090_abnormal_vision | 0.58555903 |
| 170 | MP0003633_abnormal_nervous_system | 0.57916211 |
| 171 | MP0000613_abnormal_salivary_gland | 0.57692284 |
| 172 | MP0004133_heterotaxia | 0.57205500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Limb dystonia (HP:0002451) | 4.59943000 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.56950420 |
| 3 | Neurofibrillary tangles (HP:0002185) | 4.21339215 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 4.03764403 |
| 5 | Focal motor seizures (HP:0011153) | 4.02216021 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 3.90314264 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.90198731 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.88815488 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.78630559 |
| 10 | Myokymia (HP:0002411) | 3.64063628 |
| 11 | Parakeratosis (HP:0001036) | 3.52827034 |
| 12 | Acute encephalopathy (HP:0006846) | 3.49245159 |
| 13 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.32113528 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.29587513 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.29587513 |
| 16 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.27767518 |
| 17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.27767518 |
| 18 | Macrocytic anemia (HP:0001972) | 3.18503568 |
| 19 | Optic disc pallor (HP:0000543) | 3.15999272 |
| 20 | Atonic seizures (HP:0010819) | 3.15435671 |
| 21 | Abnormal ciliary motility (HP:0012262) | 3.14076077 |
| 22 | Lactic acidosis (HP:0003128) | 3.13614113 |
| 23 | Increased hepatocellular lipid droplets (HP:0006565) | 3.13524728 |
| 24 | Increased serum lactate (HP:0002151) | 3.11105206 |
| 25 | Methylmalonic acidemia (HP:0002912) | 3.08861916 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.06774624 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 3.01205757 |
| 28 | Focal seizures (HP:0007359) | 3.00800892 |
| 29 | Type I transferrin isoform profile (HP:0003642) | 2.96901068 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 2.95822373 |
| 31 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.94256049 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.93870559 |
| 33 | Absent/shortened dynein arms (HP:0200106) | 2.93870559 |
| 34 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.93026754 |
| 35 | Increased CSF lactate (HP:0002490) | 2.92391505 |
| 36 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.85661370 |
| 37 | Methylmalonic aciduria (HP:0012120) | 2.84003795 |
| 38 | Leukodystrophy (HP:0002415) | 2.83580786 |
| 39 | Congenital, generalized hypertrichosis (HP:0004540) | 2.83036160 |
| 40 | Reticulocytopenia (HP:0001896) | 2.82601611 |
| 41 | Pheochromocytoma (HP:0002666) | 2.81798663 |
| 42 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.81755538 |
| 43 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.77847100 |
| 44 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.77847100 |
| 45 | Cerebral hemorrhage (HP:0001342) | 2.77646355 |
| 46 | Hepatocellular necrosis (HP:0001404) | 2.77634441 |
| 47 | Visual hallucinations (HP:0002367) | 2.72960983 |
| 48 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.70561845 |
| 49 | Peripheral hypomyelination (HP:0007182) | 2.67156227 |
| 50 | Neuroendocrine neoplasm (HP:0100634) | 2.65798209 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64138417 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 2.62684248 |
| 53 | Lethargy (HP:0001254) | 2.60439074 |
| 54 | Hyperventilation (HP:0002883) | 2.57371969 |
| 55 | Broad-based gait (HP:0002136) | 2.56932791 |
| 56 | Respiratory difficulties (HP:0002880) | 2.54899720 |
| 57 | Reduced antithrombin III activity (HP:0001976) | 2.53981653 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.53707744 |
| 59 | Aplastic anemia (HP:0001915) | 2.52262803 |
| 60 | Abnormality of the corticospinal tract (HP:0002492) | 2.49569804 |
| 61 | Meckel diverticulum (HP:0002245) | 2.47839039 |
| 62 | Increased muscle lipid content (HP:0009058) | 2.47414800 |
| 63 | Oral leukoplakia (HP:0002745) | 2.46282851 |
| 64 | Hypothermia (HP:0002045) | 2.45864418 |
| 65 | Dysmetria (HP:0001310) | 2.41889274 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.39579078 |
| 67 | Epileptic encephalopathy (HP:0200134) | 2.36401647 |
| 68 | Vaginal atresia (HP:0000148) | 2.35800064 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.35041721 |
| 70 | Abnormal protein glycosylation (HP:0012346) | 2.35041721 |
| 71 | Abnormal glycosylation (HP:0012345) | 2.35041721 |
| 72 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.35041721 |
| 73 | Abnormality of the ileum (HP:0001549) | 2.34107769 |
| 74 | Abnormality of the parathyroid morphology (HP:0011766) | 2.33729687 |
| 75 | Degeneration of anterior horn cells (HP:0002398) | 2.32943702 |
| 76 | Abnormality of the anterior horn cell (HP:0006802) | 2.32943702 |
| 77 | Amblyopia (HP:0000646) | 2.32704624 |
| 78 | Genital tract atresia (HP:0001827) | 2.31719346 |
| 79 | Dialeptic seizures (HP:0011146) | 2.30683016 |
| 80 | Abnormality of the labia minora (HP:0012880) | 2.29201138 |
| 81 | Megaloblastic anemia (HP:0001889) | 2.28963257 |
| 82 | Esotropia (HP:0000565) | 2.28422480 |
| 83 | Supranuclear gaze palsy (HP:0000605) | 2.27497049 |
| 84 | Abnormal pupillary function (HP:0007686) | 2.27196988 |
| 85 | 3-Methylglutaconic aciduria (HP:0003535) | 2.25042960 |
| 86 | Microvesicular hepatic steatosis (HP:0001414) | 2.24583195 |
| 87 | Abnormality of the preputium (HP:0100587) | 2.24356336 |
| 88 | Abnormality of chromosome stability (HP:0003220) | 2.23772059 |
| 89 | Absence seizures (HP:0002121) | 2.21910314 |
| 90 | Colon cancer (HP:0003003) | 2.21445475 |
| 91 | Retinal dysplasia (HP:0007973) | 2.19804651 |
| 92 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.19064589 |
| 93 | Glycosuria (HP:0003076) | 2.19003687 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 2.19003687 |
| 95 | Cerebral edema (HP:0002181) | 2.18279185 |
| 96 | Delusions (HP:0000746) | 2.16600451 |
| 97 | Amniotic constriction ring (HP:0009775) | 2.15591243 |
| 98 | Abnormality of placental membranes (HP:0011409) | 2.15591243 |
| 99 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15467215 |
| 100 | Abnormality of alanine metabolism (HP:0010916) | 2.15467215 |
| 101 | Hyperalaninemia (HP:0003348) | 2.15467215 |
| 102 | CNS demyelination (HP:0007305) | 2.12398034 |
| 103 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.11084709 |
| 104 | Pancreatic fibrosis (HP:0100732) | 2.10259069 |
| 105 | Pancreatic cysts (HP:0001737) | 2.10107517 |
| 106 | Respiratory failure (HP:0002878) | 2.09440754 |
| 107 | Generalized aminoaciduria (HP:0002909) | 2.08909419 |
| 108 | Hyperglycinemia (HP:0002154) | 2.07645642 |
| 109 | Abnormality of the axillary hair (HP:0100134) | 2.07436814 |
| 110 | Abnormality of secondary sexual hair (HP:0009888) | 2.07436814 |
| 111 | Pancytopenia (HP:0001876) | 2.06896224 |
| 112 | Febrile seizures (HP:0002373) | 2.06706812 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 2.06411940 |
| 114 | Exercise intolerance (HP:0003546) | 2.05806882 |
| 115 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.05263639 |
| 116 | X-linked dominant inheritance (HP:0001423) | 2.03555866 |
| 117 | Abnormal lung lobation (HP:0002101) | 2.02230229 |
| 118 | Cupped ear (HP:0000378) | 2.01712258 |
| 119 | Alacrima (HP:0000522) | 2.01003788 |
| 120 | Chromsome breakage (HP:0040012) | 2.00511745 |
| 121 | Anxiety (HP:0000739) | 2.00499445 |
| 122 | True hermaphroditism (HP:0010459) | 1.98359582 |
| 123 | Sparse eyelashes (HP:0000653) | 1.98036628 |
| 124 | Gait imbalance (HP:0002141) | 1.97972326 |
| 125 | Polyphagia (HP:0002591) | 1.97304110 |
| 126 | Increased serum pyruvate (HP:0003542) | 1.94152578 |
| 127 | Abnormality of glycolysis (HP:0004366) | 1.94152578 |
| 128 | Abnormality of renal resorption (HP:0011038) | 1.93598586 |
| 129 | Pallor (HP:0000980) | 1.92805219 |
| 130 | Stenosis of the external auditory canal (HP:0000402) | 1.91305728 |
| 131 | Hypoglycemic coma (HP:0001325) | 1.91154175 |
| 132 | Hyperphosphaturia (HP:0003109) | 1.90666846 |
| 133 | Generalized tonic-clonic seizures (HP:0002069) | 1.90229599 |
| 134 | Medial flaring of the eyebrow (HP:0010747) | 1.89639569 |
| 135 | Anomalous pulmonary venous return (HP:0010772) | 1.87294484 |
| 136 | Rhinitis (HP:0012384) | 1.87112533 |
| 137 | Testicular atrophy (HP:0000029) | 1.87023808 |
| 138 | Spastic gait (HP:0002064) | 1.86684988 |
| 139 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.85790412 |
| 140 | Abnormality of vitamin B metabolism (HP:0004340) | 1.85531048 |
| 141 | J-shaped sella turcica (HP:0002680) | 1.83927263 |
| 142 | Birth length less than 3rd percentile (HP:0003561) | 1.83422962 |
| 143 | Abnormality of midbrain morphology (HP:0002418) | 1.83414790 |
| 144 | Molar tooth sign on MRI (HP:0002419) | 1.83414790 |
| 145 | Hyperthyroidism (HP:0000836) | 1.81400517 |
| 146 | Septo-optic dysplasia (HP:0100842) | 1.80904421 |
| 147 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.80596660 |
| 148 | Hepatic necrosis (HP:0002605) | 1.79677868 |
| 149 | Akinesia (HP:0002304) | 1.79582399 |
| 150 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77308558 |
| 151 | Dicarboxylic aciduria (HP:0003215) | 1.77308558 |
| 152 | Congenital primary aphakia (HP:0007707) | 1.76669168 |
| 153 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.76606851 |
| 154 | Hypoplastic pelvis (HP:0008839) | 1.75629213 |
| 155 | Infantile muscular hypotonia (HP:0008947) | 1.75538570 |
| 156 | Small intestinal stenosis (HP:0012848) | 1.75523308 |
| 157 | Duodenal stenosis (HP:0100867) | 1.75523308 |
| 158 | Hemiparesis (HP:0001269) | 1.75003192 |
| 159 | Atelectasis (HP:0100750) | 1.74403400 |
| 160 | Progressive external ophthalmoplegia (HP:0000590) | 1.73126135 |
| 161 | Diminished movement (HP:0002374) | 1.71838707 |
| 162 | Termporal pattern (HP:0011008) | 1.71833061 |
| 163 | Insidious onset (HP:0003587) | 1.71833061 |
| 164 | Abnormality of the pulmonary veins (HP:0011718) | 1.71253367 |
| 165 | Blindness (HP:0000618) | 1.70868385 |
| 166 | Progressive inability to walk (HP:0002505) | 1.68838857 |
| 167 | Thickened helices (HP:0000391) | 1.68743686 |
| 168 | Sclerocornea (HP:0000647) | 1.68740324 |
| 169 | Increased circulating renin level (HP:0000848) | 1.68726778 |
| 170 | Chin dimple (HP:0010751) | 1.66589179 |
| 171 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66257927 |
| 172 | Exertional dyspnea (HP:0002875) | 1.65966171 |
| 173 | Drooling (HP:0002307) | 1.65917496 |
| 174 | Triphalangeal thumb (HP:0001199) | 1.64215789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.34413813 |
| 2 | BUB1 | 4.14312903 |
| 3 | PNCK | 4.11257026 |
| 4 | STK39 | 3.64791290 |
| 5 | CDK19 | 3.08322890 |
| 6 | CASK | 2.92300026 |
| 7 | EIF2AK1 | 2.81315780 |
| 8 | SRPK1 | 2.79099980 |
| 9 | CDC7 | 2.76154229 |
| 10 | NEK1 | 2.72017254 |
| 11 | ZAK | 2.56290783 |
| 12 | EIF2AK3 | 2.51888671 |
| 13 | EPHA4 | 2.51386338 |
| 14 | OXSR1 | 2.44770304 |
| 15 | TNIK | 2.39555262 |
| 16 | MAPKAPK5 | 2.34456828 |
| 17 | GRK5 | 2.27876957 |
| 18 | MAP3K12 | 2.14379027 |
| 19 | PLK3 | 2.10284707 |
| 20 | TTK | 2.05034870 |
| 21 | NTRK3 | 2.04531575 |
| 22 | FGR | 2.04364357 |
| 23 | TSSK6 | 1.95220095 |
| 24 | NUAK1 | 1.89688290 |
| 25 | MARK1 | 1.89098995 |
| 26 | CSNK1G3 | 1.86131551 |
| 27 | PLK4 | 1.85212748 |
| 28 | BRSK2 | 1.80171241 |
| 29 | NME1 | 1.80072582 |
| 30 | WEE1 | 1.79440704 |
| 31 | BCR | 1.78465420 |
| 32 | TRIM28 | 1.77400501 |
| 33 | RIPK4 | 1.72995145 |
| 34 | FES | 1.70476837 |
| 35 | MAP2K7 | 1.68783192 |
| 36 | MAP3K4 | 1.67405018 |
| 37 | WNK4 | 1.66428910 |
| 38 | MKNK1 | 1.65697803 |
| 39 | NTRK1 | 1.60542883 |
| 40 | MKNK2 | 1.57910877 |
| 41 | PKN1 | 1.57511182 |
| 42 | PLK2 | 1.54445654 |
| 43 | MAPK13 | 1.52733792 |
| 44 | MST4 | 1.51731940 |
| 45 | TAF1 | 1.51675511 |
| 46 | ARAF | 1.49800739 |
| 47 | GRK7 | 1.48169467 |
| 48 | CSNK1G2 | 1.44772979 |
| 49 | CAMK2B | 1.42616901 |
| 50 | PLK1 | 1.38728037 |
| 51 | ADRBK2 | 1.37397584 |
| 52 | UHMK1 | 1.36683933 |
| 53 | CSNK1G1 | 1.33637484 |
| 54 | BMPR1B | 1.31981440 |
| 55 | MAP2K4 | 1.31440931 |
| 56 | MAP3K9 | 1.28888134 |
| 57 | BCKDK | 1.26891538 |
| 58 | IRAK2 | 1.26729637 |
| 59 | PTK2B | 1.26111787 |
| 60 | CAMK2D | 1.25256628 |
| 61 | CAMK2A | 1.23662995 |
| 62 | PDK2 | 1.17745923 |
| 63 | BMPR2 | 1.15096661 |
| 64 | BRSK1 | 1.11856613 |
| 65 | MAP4K2 | 1.09961816 |
| 66 | MINK1 | 1.09815029 |
| 67 | ROCK2 | 1.09748926 |
| 68 | TLK1 | 1.07891937 |
| 69 | AURKB | 1.07061505 |
| 70 | STK16 | 1.04170541 |
| 71 | LIMK1 | 0.99777104 |
| 72 | TYRO3 | 0.99583231 |
| 73 | PBK | 0.97295005 |
| 74 | ERBB3 | 0.94547093 |
| 75 | CDK5 | 0.93741392 |
| 76 | EIF2AK2 | 0.93612305 |
| 77 | MAPK15 | 0.93353505 |
| 78 | ADRBK1 | 0.93076889 |
| 79 | IRAK1 | 0.92104348 |
| 80 | GRK6 | 0.88661851 |
| 81 | CSNK1A1L | 0.88369577 |
| 82 | CDK14 | 0.88151478 |
| 83 | PAK4 | 0.87016826 |
| 84 | MUSK | 0.86911247 |
| 85 | NTRK2 | 0.84649106 |
| 86 | WNK1 | 0.80173322 |
| 87 | ATR | 0.80007451 |
| 88 | CDK11A | 0.79691824 |
| 89 | DYRK2 | 0.79594277 |
| 90 | CCNB1 | 0.79138532 |
| 91 | STK38L | 0.78778469 |
| 92 | INSRR | 0.77293973 |
| 93 | CHEK2 | 0.76876225 |
| 94 | CDK15 | 0.75326805 |
| 95 | NEK6 | 0.74208984 |
| 96 | CDK18 | 0.72961304 |
| 97 | PRKD2 | 0.71545090 |
| 98 | PRKCQ | 0.71380551 |
| 99 | EPHB1 | 0.71380412 |
| 100 | CAMK2G | 0.69389945 |
| 101 | STK4 | 0.69216691 |
| 102 | PRKCG | 0.68918580 |
| 103 | CSNK2A2 | 0.68720911 |
| 104 | PRKCE | 0.67094312 |
| 105 | CSNK2A1 | 0.65993117 |
| 106 | CDK8 | 0.65845656 |
| 107 | PHKG2 | 0.65227172 |
| 108 | PHKG1 | 0.65227172 |
| 109 | AURKA | 0.64899781 |
| 110 | DYRK3 | 0.64807773 |
| 111 | ACVR1B | 0.64510316 |
| 112 | DYRK1A | 0.63240173 |
| 113 | MYLK | 0.60944516 |
| 114 | NEK2 | 0.60497529 |
| 115 | SCYL2 | 0.59805963 |
| 116 | NME2 | 0.56795758 |
| 117 | ABL2 | 0.55901935 |
| 118 | PRKACA | 0.53288497 |
| 119 | DAPK1 | 0.51854051 |
| 120 | MST1R | 0.51825864 |
| 121 | ERBB4 | 0.50721857 |
| 122 | ATM | 0.50278996 |
| 123 | TESK1 | 0.49748759 |
| 124 | PASK | 0.49003312 |
| 125 | FGFR2 | 0.46729458 |
| 126 | PAK6 | 0.46541290 |
| 127 | MET | 0.46406111 |
| 128 | RPS6KA5 | 0.46170892 |
| 129 | CHEK1 | 0.46161051 |
| 130 | FYN | 0.45937420 |
| 131 | CDK7 | 0.45415090 |
| 132 | VRK1 | 0.44958319 |
| 133 | STK3 | 0.44118594 |
| 134 | PAK3 | 0.43640658 |
| 135 | MAP3K2 | 0.43530206 |
| 136 | KSR2 | 0.42723189 |
| 137 | PIM2 | 0.42211578 |
| 138 | CSNK1E | 0.41461554 |
| 139 | ILK | 0.41062840 |
| 140 | MAP3K13 | 0.40328432 |
| 141 | RPS6KA4 | 0.40140954 |
| 142 | CDK3 | 0.39131866 |
| 143 | MOS | 0.38889360 |
| 144 | FGFR1 | 0.38639186 |
| 145 | BRAF | 0.36714165 |
| 146 | CAMK1G | 0.36314388 |
| 147 | CSNK1A1 | 0.33081627 |
| 148 | WNK3 | 0.32408997 |
| 149 | PRKG1 | 0.31934765 |
| 150 | PRKCI | 0.30756362 |
| 151 | FRK | 0.30425226 |
| 152 | STK11 | 0.29653981 |
| 153 | PRKCZ | 0.29509020 |
| 154 | GRK1 | 0.29285922 |
| 155 | DAPK3 | 0.28734224 |
| 156 | SIK2 | 0.28006304 |
| 157 | RET | 0.27902278 |
| 158 | EPHB2 | 0.27471829 |
| 159 | KDR | 0.26828999 |
| 160 | OBSCN | 0.26710323 |
| 161 | ALK | 0.26271539 |
| 162 | CDK1 | 0.26233819 |
| 163 | TGFBR1 | 0.25572228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.90271499 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.00330598 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 3.36736183 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.10334337 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.07175304 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.95385522 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.92163160 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.68383952 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.59429707 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.57315939 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.52621932 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.27481444 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.21017771 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.20197591 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19746762 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.04773265 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 2.01568775 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01413688 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.01407731 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98889889 |
| 21 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92985988 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.89808080 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87259235 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.85488640 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.81800833 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.75584188 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.71742807 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.69196617 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68935568 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.68273703 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.68088613 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66147187 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65464147 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64971707 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.64413157 |
| 36 | * Ribosome_Homo sapiens_hsa03010 | 1.63924502 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.61995274 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.59252068 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.57031867 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56593139 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.55853625 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55533580 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.52904631 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50844484 |
| 45 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.49364536 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 1.48900744 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.47688716 |
| 48 | Protein export_Homo sapiens_hsa03060 | 1.47479288 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 1.46330983 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 1.39489922 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35153503 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34609740 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 1.32280430 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32210909 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31068669 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 1.25295837 |
| 57 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19970564 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 1.19407490 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19220615 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 1.18378994 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15274569 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14853716 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07118513 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05978828 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05372332 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.05328868 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05322145 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03376579 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95267173 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94277944 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.93760079 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90858257 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88430275 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87702351 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86699878 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84646468 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83902570 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79362284 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77903424 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77696423 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77492388 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76536887 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.76283553 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75672251 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.74236410 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.73875017 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73805045 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73387031 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73023832 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72134695 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70661145 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.68550765 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67646584 |
| 94 | Proteasome_Homo sapiens_hsa03050 | 0.67386437 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66414345 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65920718 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63603844 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62698358 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61942028 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60830053 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60092259 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59096581 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58459293 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58066993 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57752339 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56742423 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56660395 |
| 108 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56101305 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.55126762 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55051374 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53408157 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52596012 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50759012 |
| 114 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50736496 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50620330 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49385808 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48696277 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48272202 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47839250 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47126331 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.46703165 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46650641 |
| 123 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45690370 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45571344 |
| 125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43597113 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42483256 |
| 127 | RNA polymerase_Homo sapiens_hsa03020 | 0.41806714 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41352379 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.40938963 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40608803 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39819683 |
| 132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39325250 |
| 133 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39203466 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38768683 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38742811 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37823109 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36257862 |
| 138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36112192 |
| 139 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35829282 |
| 140 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35553176 |
| 141 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35010121 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34656934 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34211855 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.34084750 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34061621 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30847654 |
| 147 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29118334 |
| 148 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.28829789 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28096562 |
| 150 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26713089 |
| 151 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26599041 |
| 152 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25744027 |
| 153 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25452294 |
| 154 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24509561 |
| 155 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24494359 |
| 156 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.24127244 |
| 157 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23760885 |
| 158 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.22848268 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21551642 |
| 160 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19900033 |
| 161 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18538221 |
| 162 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.18263408 |
| 163 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.16778345 |
| 164 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16331413 |
| 165 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16101301 |
| 166 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13540575 |
| 167 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10830600 |
| 168 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.10089454 |
| 169 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.06972192 |

